Global Drug R&D Express (Oct. 2022)

阅读全文

报告摘要

In October, 2022, 18 drugs were approved globally, 60 drugs were under expedited review pathway globally, and about 5 blockbuster drugs made new progress in clinical research.

立即开始免费试用!

智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。

立即开始数据试用!

智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。